Drdgold Ltd-sponsored Adr (DRD) Institutional Investor Snapshot (105 Funds, Q2 2026)

DRD ranks #4476 out of 37503 tracked stocks by institutional interest, inside the more closely watched half of our coverage.

105 institutions disclose a position in DRD, but none treat it as a major bet — even Towarzystwo Funduszy Inwestycyjnych Allianz Polska S.A., its most concentrated holder, allocates just 0.9% of its own portfolio to it.

Quadrature Capital Ltd has added to its DRD position for two straight quarters, increasing it by $2.2M to reach $2.5M today.

Arrowstreet Capital, Limited Partnership has trimmed its DRD position for two straight quarters, cutting it by $26.0M while still holding $6.6M.

DRD is up 2.1% today, but institutions show net selling of $22.7M this quarter — a divergence between today's price move and the underlying institutional flow.

DRD closed its latest fiscal year with net income of $2.2B.

• Profitable — net income of $2.2B in the latest fiscal year
• Revenue grew 26.3% year over year
• Net income improved year over year, from $1.3B to $2.2B
• Generated $3.5B in positive operating cash flow
• Current ratio of 2.28x — enough short-term assets to cover short-term liabilities
• Liabilities run 0.38x equity — within a conventional range